Kurtz Ronald M MD
- SEC CIK
- 0001295469
In the past year, 1 open-market sale filing worth $35.5K and no purchases.
Current role at each company
- RXST RxSight, Inc.Chief Medical Officeras of Sep 9, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $35.5K
- 1 filing
- Net
- −$35.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kurtz Ronald M MD as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 (view filing)9:35 PM ET | Sep 2 | Same day | Kurtz Ronald M MDChief Medical Officer | SSale | −5.10K | $6.96 | −$35.5K | −6.6%71.8K after | |
| May 6, 2024 (view filing) | May 3 | 3 days | Kurtz Ronald M MDPresident & CEO | SSale | −40.0K | $60.15 | −$2.41M | −5.0%764.6K after | 10b5-1 |
| Jan 9, 2024 (view filing) | Jan 8 | 1 day | Kurtz Ronald M MDPresident & CEO | SSale | −62.5K | $44.25 | −$2.77M | −7.2%804.6K after | 2 lots10b5-1 |
| Dec 29, 2023 (view filing) | Dec 27 | 2 days | Kurtz Ronald M MDPresident & CEO | SSale | −22.5K | $41.09 | −$924.5K | −2.5%867.1K after | 10b5-1 |
| Dec 18, 2023 (view filing) | Dec 14 | 4 days | Kurtz Ronald M MDPresident & CEO | SSale | −40.0K | $39.71 | −$1.59M | −4.3%889.6K after | 2 lots10b5-1 |
| Aug 5, 2021 (view filing) | Aug 3 | 2 days | Kurtz Ronald M MDSee Remarks | PPurchase | +125.0K | $16.00 | +$2.00M | New position125.0K after | |
| Aug 5, 2021 (view filing) | Aug 5 | Same day | Kurtz Ronald M MDSee Remarks | PPurchase | +3.64K | $13.85 | +$50.4K | +0.5%804.6K after |